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The baculovirus protein IE1 is required for the transactivation of many early viral genes in transient expression assays.
However, cycloheximide inhibition studies have failed to reveal a dependence of early gene transcription on expression of
IE1 in infected cells. We show here that synthesis of IE1 was not effectively inhibited by the addition of 100 mg/ml
cycloheximide, the concentration routinely used in these studies. However, when cycloheximide was added at 250 mg/ml,
IE1 synthesis was repressed to less than 5% of control levels. These more stringent conditions were used to discriminate
between immediate early and delayed early genes. Transcription of three immediate early genes (ie1, ie2, and ie0) was
increased by the addition of high concentrations of cycloheximide. However, transcription of three other early genes (39k,
p35, and lef-3), which are known to be dependent on IE1 transactivation, was significantly reduced by the addition of 250
mg/ml cycloheximide. Immunoblot analyses also revealed a difference between the immediate and delayed early class of
viral genes. Synthesis of IE1, IE2, and IE0 was resistant to cycloheximide treatment, while translation of SSB/LEF-3 and
pp31 was strongly inhibited even at the lower concentration of cycloheximide. Although cycloheximide was shown to be
useful in defining early temporal classes, it induced apoptosis in both uninfected and infected Sf9 cells when used at the
inhibitory concentration. q 1997 Academic Press
INTRODUCTION with cycloheximide failed to distinguish between differ-
ent early genes. All early genes, including several known
Viral gene expression in Autographa californica to be transactivated by IE1 in transfection assays, were
multicapsid nuclear polyhedrosis virus (AcMNPV)-in- transcribed in the presence of cycloheximide (Friesen
fected cells is temporally regulated. Viral genes are clas- and Miller, 1985; Li et al., 1993; Tomalski et al., 1988;
sified as early or late based upon their time of expression Morris et al., 1994; Guarino and Summers, 1987).
relative to the onset of viral DNA synthesis. Early genes Theoretically, these two methods should have resulted
are transcribed prior to DNA replication, while late genes in the same classifications for early genes. One explana-
are transcribed postreplication. Early genes can be fur- tion proposed for the differences was that IE1 might be
ther divided into immediate-early or delayed-early based a viral structural protein (Miller, 1988). Thus, transfection
upon their requirements for viral gene products. Two assays would require plasmids encoding IE1, but infec-
methods have been used for the classification of immedi- tion assays would not require de novo synthesis of IE1
ate early and delayed early genes. Guarino and col- because it would enter cells as part of the viral particle.
leagues (Guarino and Summers, 1986; Carson et al., A second possibility is that cycloheximide might not ef-
1988; Kovacs et al., 1991) used transient expression fectively inhibit translation of IE1 in infected cells. Very
assays to identify three immediate early genes (ie1, ie2, low levels of IE1 are sufficient for the activation of the
and ie0), which are highly expressed in the absence of delayed early 39k gene (Choi and Guarino, 1995); thus,
other viral factors. They also defined a delayed early sufficient IE1 might be produced in the presence of cyclo-
class of genes which are dependent upon ie1 and viral heximide for full activation of delayed early genes.
enhancer elements for maximal expression. Studies performed on Orgyia pseudotsugata multicap-
An alternative method for the classification of early sid nuclear polyhedrosis virus (OpMNPV) supported the
genes involves the use of cycloheximide as an inhibitor former possibility (Theilman and Stewart, 1993). Mono-
of translation in infected cells (Rice and Miller, 1986). clonal antibody raised against IE1 was used to demon-
The premise of this methodology is that inhibition of ex- strate the presence of IE1 in purified preparations of
pression of immediate-early genes should inhibit tran- budded virus. However, the amount of IE1 in AcMNPV
scription of delayed early genes. Numerous experiments was found to be less than one molecule per virion, sug-
gesting that IE1 is not a structural protein of budded
virus, at least for AcMNPV (Choi and Guarino, 1995b).1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (409) 845-9274. E-mail: Iguarino@bioch.tamu.edu. The aim of this study was to determine whether cyclo-
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heximide effectively blocked the synthesis of IE1 in in- Aliquots (50 ml) of the protein extracts were fraction-
ated on 8% SDS–polyacrylamide gels. The proteins werefected cells. We found that the conditions commonly
used in cycloheximide-blocking experiments only mod- then transferred to a nitrocellulose membrane using a
semi-dry apparatus (Harlow and Lane, 1988). The immu-estly reduced IE1 expression. Complete inhibition of IE1
synthesis required both higher levels of inhibitor and a noreaction was performed with monoclonal antiserum
4B9 at a dilution of 1:1000. Antigen–antibody complexeslonger preincubation period prior to infection. Using the
newly defined conditions, we were able to differentiate were detected with alkaline phosphatase-conjugated
goat anti-mouse immunoglobin G, and the immunoblotsbetween the two early classes of viral genes in infected
cells. were developed using BCIP/NBT substrate. Quantitation
of IE1 on immunoblots was performed using NIH Image.
Serial dilutions of samples were analyzed to ensure thatMETHODS
proteins were within a linear range.
Cells and virus
RNA Isolation and primer extension analysis
Spodoptera frugiperda (Sf9) cells were passaged in
Sf9 cells (1.5 1 107) were mock-infected or infectedspinner flasks at 277 and infected as previously de-
with wild-type AcMNPV at a multiplicity of 10 PFU. Priorscribed (Summers and Smith, 1987). Cells were infected
to infection, cells were treated with 100 mg/ml cyclohexi-with wild-type AcMNPV at a multiplicity of 10 PFU per
mide for 1 hr or with 250 mg/ml cycloheximide for 2 hr.cell.
Subsequent media contained the same cycloheximide
concentration. At 6 hr postinfection, the cells were har-Cycloheximide inhibition assays
vested and total cellular RNA was isolated by guanidi-
Sf9 cells (2.5 1 105) were seeded in 16-mm flat-bottom nium isothiocyanate centrifugation (Chirgwin et al., 1979).
culture plates. The cells were allowed to form a mono- RNA was also isolated from uninfected control cells
layer in the presence of 0, 50, 100, 150, 200, 250, or 300 which were not treated with cycloheximide.
mg/ml of cycloheximide. Stock solutions of cycloheximide Oligonucleotides complementary to a sequence near the
were made at a concentration of 50 mg/ml in ethanol. N-terminus of open reading frames for ie1, ie2, 39k, p35,
The cells were preincubated in the presence of cyclohex- and lef-3 were 5* end-labeled using T4 polynucleotide ki-
imide for 1 or 2 hr before infection, as indicated. The cells nase (Promega). The probes (0.5 ng) were then separately
were then incubated with virus for 1 hr, in the presence of hybridized with 20 mg of total RNA, and the primers were
the same concentrations of cycloheximide. The inoculum extended using AMV reverse transcriptase (Promega). The
was removed and replaced with Grace’s media plus 0.5% products were separated on 6% polyacrylamide–8 M urea
fetal bovine serum and cycloheximide of the same con- gels and detected by autoradiography.
centration as used during pretreatment and infection. Six
hours after removing the inoculum, the cells were DNA fragmentation assays
washed once with PBS, and soluble proteins were ex- Sf9 cells (2 1 106) were pretreated with 0, 50, 100,
tracted with 0.4 M NaCl (Guarino and Dong, 1991). 150, 200, 250, and 300 mg/ml of cycloheximide for 2 hr,
For measurements of total protein synthesis, cells and then infected with wild-type AcMNPV in the presence
were treated as described above, except that cells were of the same concentrations of cycloheximide. The inocu-
incubated in the presence of Grace’s medium minus me- lum was removed and replaced with Grace’s medium
thionine and 10 mCi/ml of [35S]methionine and cysteine and cycloheximide at the same concentrations. At 6 hr
for the 6-hr period. Radiolabeled proteins were extracted postinfection, the cells were harvested and centrifuged
in 0.2 ml of extraction buffer [50 mM Tris (pH 8.0), 100 at 47. The pellets were washed once with cold PBS and
mM NaCl, 1% NP-40], as previously described. Incorpora- resuspended in 300 ml of a buffer consisting of 10 mM
tion of radiolabel into acid-insoluble material was deter- Tris–HCl (pH 7.5), 10 mM EDTA, and 0.2% Triton-X100
mined by TCA precipitation. (Ishida et al., 1991). The lysates were extracted on ice
for 10 min and then centrifuged at 47. The supernatantWestern blot analysis
was extracted with phenol and precipitated with ethanol.
The precipitated DNA was resuspended in 15 ml TEAntisera against pp31 (Guarino et al., 1992), SSB (Hang
et al., 1995), and IE2 (Yoo and Guarino, 1993) have been buffer and treated with 0.6 mg/ml RNase for 5 min at 377
and subsequently electrophoresed on a 2% agarose gelpreviously described. Monoclonal antibody 4B9 was
raised against IE1 using standard protocols for immuni- and visualized using ethidium-bromide staining.
zation, fusion, and ELISA detection of positive hybrido-
Cell viability determinationmas (Harlow and Lane, 1988). Inclusion bodies prepared
from overexpressing bacteria were used as antigen as Sf9 cells (2 1 106) were pretreated for 1 hr in 100 mg/
ml cycloheximide or for 2 hr at 250 mg/ml cycloheximidepreviously described (Kovacs et al., 1992).
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and then infected or mock-infected at 10 PFU per cell we performed a time course analysis of IE1 accumulation
(Fig. 2). In untreated infected cells, IE1 could not be de-and allowed to incubate for 6 hr at 277. The cells were
then treated with 0.04% trypan blue for 5 min. The num- tected at 1 hr postinfection, but was evident by 2 hr
postinfection. IE1 accumulated steadily from 2 to 8 hrbers of viable and total cells were counted in a hemocy-
tometer. postinfection (Fig. 2, lanes 2–7). This time dependence
of IE1 detection suggests that the protein is newly syn-
RESULTS thesized in infected cells. In cells treated with cyclohexi-
mide at 100 mg/ml, IE1 was not detected until 4 hr postin-Cycloheximide inhibition of IE1 synthesis
fection, and protein continued to accumulate through the
The standard conditions used for cycloheximide inhibi- end of the time course. However, IE1 and IE0 are only
tion studies are a concentration of 100 mg/ml and a pre- barely detectable at the end of the time course when the
treatment time of 1 hr, with subsequent use of cyclohexi- cells were pretreated for 2 hr at a concentration of 250
mide at the same concentration in all media. Using these mg/ml.
conditions, Rice and Miller (1986) reported that synthesis
of total proteins in cycloheximide-treated cells was Primer extension analysis
strongly inhibited. However, they observed low levels of
To determine whether the more stringent conditionsprotein synthesis, indicating that cycloheximide inhibition
for cycloheximide-inhibition would be useful in distin-was leaky. To study the effectiveness of cycloheximide
guishing between the two early classes of genes, primeron inhibition of IE1, we pretreated cells for 1 hr in the
extension reactions were performed using oligonucleo-presence of cycloheximide at concentrations between 0
tide primers for ie0, ie1, ie2, 39k, p35, lef3, and DNA poland 300 mg/ml. At 6 hr postinfection, the cells were har-
(Fig. 3). Similar to previous reports, we found that all ofvested and the synthesis of IE1 was monitored by West-
the early genes were transcribed in the presence of 100ern analysis (Fig. 1A, lanes 1–8).
mg/ml of cycloheximide. However, even at this concentra-In the absence of cycloheximide, bands corresponding
tion, we noted differences in the response of the genesto IE1 and IE0 were clearly resolved (Fig. 1A, lane 2).
to cycloheximide treatment. Transcription of ie1, ie2, andSynthesis of both proteins was also detected at all con-
ie0 was increased in the cycloheximide-treated cells,centrations of cycloheximide tested. Synthesis of IE0 was
while 39k, p35, lef-3, and dnapol were transcribed at themore resistant to cycloheximide inhibition than was IE1.
same level as in the control cells. This difference is evenQuantitation of immunoblots (Fig. 1B) revealed that at
more evident in the cells treated at 250 mg/ml. In these100 mg/ml of cycloheximide, IE1 was expressed at 15%
cells, synthesis of ie1 was increased 2-fold while ie0of control levels, while IE0 was expressed at 43% of the
and ie2 were increased 6.4- and 2.8-fold, respectively.control. At 300 mg/ml, expression of IE1 was at 3% of the
However, synthesis of the other four early genes wascontrol levels while IE0 was at 15% of control levels. Total
strongly repressed at the higher concentration of cyclo-protein synthesis was strongly inhibited by the addition
heximide. The multiple bands in the 39k panel are dueof cycloheximide, but radiolabeled methionine was incor-
to tandem TATA boxes in the 39k promoter, as previouslyporated into acid-insoluble material even at high concen-
shown (Guarino and Smith, 1992).trations of cycloheximide. In addition, SDS–polyacryl-
amide gel analysis of [35S]methionine-labeled proteins
Immunoblot analysis of immediate and delayed earlyrevealed low levels of protein synthesis (data not shown),
proteinsas previously reported (Rice and Miller, 1986).
We did not test the effect of higher concentrations of To test whether the differences in transcription of imme-
cycloheximide because at 300 mg/ml the cells appeared diate and delayed early genes was reflected at the protein
apoptotic and viability was low (data not shown). Instead, levels, we performed immunoblot analyses using antisera
we tested the effect of longer preincubation times on the raised against IE2, SSB, and pp31 (Fig. 4). IE2 is a transcrip-
synthesis of IE1 (Fig. 1, lanes 13–18). When cells were tional activator encoded by the ie2 gene (Yoo and Guarino,
infected after 2 hr of pretreatment with cycloheximide, 1994). SSB is a single-stranded DNA binding protein and
synthesis of IE1 and IE0 were decreased as compared is the product of the lef-3 gene (Hang et al., 1995). pp31 is
to the 1-hr preincubation. At a cycloheximide concentra- a non-sequence-specific DNA binding protein and is the
tion of 300 mg/ml, IE1 synthesis was not detected, while product of the 39k gene (Guarino et al., 1992). The immu-
at 250 mg/ml, IE1 synthesis was inhibited 98% and IE0 noblots showed that synthesis of IE2 was resistant to cyclo-
was inhibited 93%. heximide treatment. Levels of IE2 were higher in cells
treated with cycloheximide than in the untreated infected
IE1 is newly synthesized in infected cells controls. Even in the cells treated with 250 mg/ml cyclohexi-
mide, significant amounts of IE2 were detected. This resultTo confirm that the IE1 protein detected in Fig. 1 was
newly synthesized and not introduced with the inoculum, is consistent with the primer extension data (Fig. 3) showing
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FIG. 1. Cycloheximide-inhibition of IE1 synthesis. Sf9 cells were pretreated at the indicated concentrations of cycloheximide for 1 hr (lanes 1–8)
or 2 hr (11–18), infected, and incubated for 6 hr at 277. Soluble proteins were extracted with 0.4 M NaCl (Guarino and Dong), separated on an 8%
SDS-gel, transferred to nitrocellulose, and probed with IE1 monoclonal antibody, 4B9. Molecular weight markers were run in lanes 9 and 10 and
the positions of the markers is shown on the left. The positions of IE1 and IE0 are indicated on the right. Cycloheximide concentrations are shown
above the lanes. B (1 hr preincubation) and C (2 hr preincubation) present quantitations of these results determined by immunoblot analysis of
serial dilutions of the samples. Total protein synthesis (B) was determined by TCA precipitation of 35S-labeled proteins. Percentage inhibition refers
to the amount of TCA precipitable counts in the cycloheximide-treated samples relative to the untreated control.
that IE2 was more strongly stimulated by cycloheximide and uninfected cells but the numbers were higher in the
infected cells (Fig. 5). After incubation in the presencethan were IE1 and IE0. The delayed early proteins SSB and
pp31 were only detected in infected cells that were not of 100 mg/ml cycloheximide, approximately 5% of the un-
infected cells were apoptotic, while 15% of the infectedtreated with cycloheximide. Therefore, cycloheximide is ef-
fective in the inhibition of delayed early protein synthesis cells showed signs of apoptotic blebbing. In the cultures
treated with 250 mg/ml of cycloheximide, 20% of the unin-even though the lower concentration of cycloheximide did
not effectively prevent transcription of delayed early RNAs. fected cells were apoptotic, while almost half of the in-
fected cells showed apoptotic morphology.
Enhanced induction of apoptosis in infected cells isInduction of apoptosis in cycloheximide-treated cells
also evident in nuclear fragmentation assays (Fig. 6). No
During the previous experiments we noted a number chromosome fragmentation was observed in uninfected
of apoptotic cells, especially at the higher concentrations cells treated at concentrations up to 300 mg/ml (Fig. 6,
of cycloheximide. To determine whether the apoptosis lane 1 and data not shown). In addition, fragmentation
was induced by infection or cycloheximide treatment, was not detected in infected cells treated with 50 or 100
cells were infected (10 PFU) or mock-infected in the pres- mg/ml cycloheximide. These observations are consistent
ence of cycloheximide concentrations ranging from 0 to with a previous observation that cycloheximide does not
induce apoptosis in S. frugiperda cells (Clem and Miller,300 mg/ml. Apoptotic cells were observed in both infected
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FIG. 2. Synthesis of IE1 in the presence of cycloheximide. Sf9 cells were infected with AcNPV at an m.o.i. of 10, and samples were withdrawn
for immunoblot analysis at 1, 2, 3, 4, 6, and 8 hr postinfection as indicated on the top. Lanes 1–7 are protein samples harvested from Sf9 cells
that were not treated with cycloheximide. Lanes 8–13 represent protein samples from cells that were pretreated with 100 mg/ml cycloheximide for
1 hr. Lanes 14–19 are samples from cells pretreated with 250 mg/ml cycloheximide for 2 hr. Migration of molecular weight markers is shown on
the left, and the positions of IE1 and IE0 are indicated on the right.
1994). However, at higher concentrations of cyclohexi- cycloheximide-treatment in both infected and uninfected
cells. The effect on viability was concentration-depen-mide, nuclear fragmentation was clearly evident (Fig. 6,
lanes 5–8). dent and was more pronounced in the infected cells than
in the uninfected controls.A more quantitative measure of apoptosis and cell
death was obtained by monitoring cell viability in infected
and uninfected cells treated with either 100 or 250 mg/ DISCUSSION
ml of cycloheximide (Fig. 7). Cell viability was reduced by
Prior to this study, the effectiveness of cycloheximide
as an inhibitor of viral immediate-early protein synthesis
FIG. 3. Primer extension analysis of early RNAs synthesized in the
presence of cycloheximide. Total RNA was harvested from infected
cells at 6 hr postinfection and 20 mg was hybridized with oligonucleo-
tide primers complementary to coding sequences for the genes indi-
cated on the right. Products of the reverse transcriptase reactions were
separated on a 6% urea–polyacrylamide gel. The autoradiograph of FIG. 4. Immunoblot analysis of IE2, SSB, and pp31 synthesis in cyclo-
heximide-treated cells. Lane 1, uninfected control; lane 2 infected cellsthe dried gel is shown. Lane 1 serves as an uninfected control. Lane
2 contains the DNA produced from RNAs harvested from infected cells not treated with cycloheximide; lane 3 cells pretreated with 100 mg/
ml of cycloheximide for 1 hr; lane 4 cells pretreated with 250 mg/mlthat were not treated with cycloheximide. Lane 3 contains products
from cells pretreated with 100 mg/ml of cycloheximide for 1 hr, while cycloheximide for 2 hr. Migration of molecular weight markers is shown
on the left, and the positions of IE2, SSB, and pp31 are indicated onlane 4 contains products obtained from cells pretreated with 250 mg/
ml cycloheximide for 2 hr. the right.
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FIG. 5. Induction of apoptosis in cycloheximide-treated Sf9 cells. Cells were pretreated for 1 hr with 100 mg/ml cycloheximide or for 2 hr with
250 mg/ml cycloheximide, infected or mock-infected for 1 hr, and allowed to incubate for 6 hr at 277. At the end of the incubation period, the cells
were photographed. The left column illustrates the level of apoptosis present in uninfected cells, while the right column represents the levels in
infected cells. Cycloheximide concentrations are shown on the left.
had not been tested. Although it had been shown that pretreatment time and concentration of cycloheximide
must be increased in order to effectively inhibit synthesiscycloheximide is able to inhibit total protein synthesis
(Rice and Miller, 1986), its effect on specific immediate- of IE1. At 100 mg/ml, synthesis of IE1 and IE0 was clearly
observed, although synthesis of these proteins was de-early products had not been demonstrated. To address
this issue, we conducted Western analysis and primer layed relative to the untreated control. Synthesis of IE1
and IE0 was very low in cells pretreated for 2 hr at 250extension experiments to learn more about the effective-
ness of this inhibitor on immediate-early and delayed- mg/ml of cycloheximide. Therefore, we recommend these
more stringent conditions for cycloheximide-inhibitionearly genes.
The first question was whether the conditions routinely studies.
In these time course analyses, IE1 and IE0 were notused for cycloheximide-inhibition studies were effective
in the control of IE1, the major transactivator of viral early detected in control or cycloheximide-treated cells at 1 hr
postinfection. This result indicates that significant levelsgene expression. Our results demonstrated that both the
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observation that reduced levels of IE1 are able to trans-
activate delayed early genes is consistent with a previ-
ous report showing that IE1 is capable of stimulating
delayed early gene expression even when added to tran-
sient assays at concentrations 1000-fold lower than nor-
mally used (Choi and Guarino, 1995). When synthesis of
IE1 was effectively blocked by the higher concentration
of cycloheximide, transcription of delayed early genes
was significantly repressed. This indicates that transcrip-
tion of 39k, p35, and lef-3 are dependent upon expression
of newly synthesized IE1 in infected cells, and therefore,
these genes should be classified as delayed-early genes.
Immunoblot analyses also showed a difference be-
tween immediate and delayed early genes. Synthesis of
the three immediate early proteins (IE0, IE1, and IE2)
was not inhibited to a significant extent by the addition
of 100 mg/ml cycloheximide. Synthesis of IE0 and IE1
were synthesized at low levels even in the presence ofFIG. 6. DNA fragmentation analysis of cycloheximide-treated cells.
250 mg/ml cycloheximide. IE2 levels were surprisinglyCells were pretreated for 2 hr with the indicated concentration of cyclo-
heximide (top of figure), infected or mock-infected for 1 hr, and allowed higher in the cycloheximide-treated cells than in the con-
to incubate for 6 hr at 277. The DNA was extracted and the samples trol cells at both concentrations of cycloheximide. How-
were treated with RNase for 5 min at 377 and subsequently electropho- ever, synthesis of two delayed early proteins (SSB and
resed on a 2% agarose gel. Ethidium bromide visualization of the DNA
pp31) was completely inhibited at both concentrations ofis shown.
cycloheximide.
Although the higher concentration of cycloheximide
used in this study was useful for making distinctionsof IE1 were not introduced into the cells as a viral struc-
tural protein (Fig. 2). This is consistent with data pre- between the two early classes, it induced apoptosis in
the infected cells. Apoptosis was evidenced by formationviously reported (Choi and Guarino, 1995), showing that
virions contain less than 1 molecule of IE1 per virion. of apoptotic bodies, chromosome fragmentation, and re-
duced cell viability (Figs. 4–6). Cycloheximide also in-Primer extension experiments were performed to de-
tect mRNAs of selected early genes. Although cyclohexi- duced apoptosis in uninfected cells, although to a lesser
mide failed to distinguish between immediate and de- extent than in the infected cells. In the uninfected cells,
layed early genes in prior studies, we were able to define
two separate types of responses to cycloheximide treat-
ment using our more stringent conditions. The mRNA
levels of ie1, ie0, and ie2 were increased in the presence
of both 100 and 250 mg/ml cycloheximide, while synthe-
sis of 39k, p35, and lef-3 was unaffected by the lower
concentration of cycloheximide and strongly repressed
by the higher one. The large increase in synthesis of
ie0 and ie2 may be due to the fact that IE1 represses
transcription of these promoters. Lower levels of IE1 in
the treated cells may lead to increased transcription of
promoters normally under negative regulation by IE1. Al-
ternatively, the increase may be due to the fact delayed
early viral protein synthesis is inhibited. Both IE2 and
IE0 are transiently synthesized in infected cells; protein
levels peak during the early phase and are not detected
during the late phase. It is possible that other viral pro-
teins, in addition to IE1, contribute to the downregulation
of ie0 and ie2 during the delayed early phase.
The delayed early transcripts (39k, p35, and lef-3) were
FIG. 7. Cell viability in cycloheximide-treated cells. Sf9 cells were
unaffected by the lower concentration of cycloheximide. pretreated for 1 hr with 100 mg/ml cycloheximide or for 2 hr with 250
At this level of cycloheximide, IE1 and IE0 were synthe- mg/ml cycloheximide. At 6 hr postinfection, cell viabilities were deter-
mined by trypan blue exclusion.sized at 15 and 43% of control levels, respectively. The
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